AveXis develops and commercializes gene therapies for the treatment of neurological genetic disorders.
Business Model:
Revenue: $15M
Employees: 1,001-5,000
Address: 2275 Half Day Road
City: Bannockburn
State: IL
Zip: 60015
Country: US
AveXis develops and commercializes gene therapies for the treatment of neurological genetic disorders.
Contact Phone:
+18475728280
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/11/2016
IPO Valuation:
$430M
Ticker Symbol:
AVXS
IPO Price:
$20/share
Amount Raised:
$95M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Series C | 2 | $10M |
Deerfield Roche Venture Fund Deerfield Roche Venture Fund |
1/2019 | Grant | 1 | $100k |
North Carolina Biotechnology Center North Carolina Biotechnology Center |
9/2015 | Series D | 12 | $65M |
QVT Financial Foresite Capital RA Capital Management Venrock Adage Capital Management Rock Springs Capital T. Rowe Price Deerfield Boxer Capital T. Rowe Price Janus Capital Group RTW Investments Roche Venture Fund QVT Financial Foresite Capital RA Capital Management Venrock Adage Capital Management Rock Springs Capital T. Rowe Price Deerfield Boxer Capital T. Rowe Price |
4/2014 | Series B | - | 7/2013 | Series A | - | 8/2015 | Series C | $10M |
Deerfield Capital Management |
3/2016 | Equity | $500k | 2/2016 | IPO | $95M | 4/2014 | Series B | - | 7/2013 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|